Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roger Prades
Observed names:
Prades, Roger,
R. Prades,
Roger Prades Cosano,
Roger Pradés
Institution:
Institute for Research in Biomedicine
Observed institutions:
University of Rochester Medicine,
Institute for Research in Biomedicine,
Barcelona Institute of Science and Technology,
Parc Científic de Barcelona,
University of Rochester,
Universitat de Barcelona
show all 6
ORCID:
0000-0001-7973-5314
Observed ORCID:
0000-0001-7973-5314
OpenAlex ID:
A5082893712
Works
40
Awards
1
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor
2012
·
Roger Prades
, Simón Guerrero
, et al.
·
Biomaterials
·
288
Applying the Retro‐Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood–Brain Barrier
2015
·
Roger Prades
, Benjamí Oller‐Salvia
, et al.
·
Angewandte Chemie International Edition
·
137
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor
2008
·
Teresa Tarragó
, Nessim Kichik
, et al.
·
Bioorganic & Medicinal Chemistry
·
98
N-Methyl Phenylalanine-Rich Peptides as Highly Versatile Blood−Brain Barrier Shuttles
2010
·
Morteza Malakoutikhah
, Roger Prades
, et al.
·
Journal of Medicinal Chemistry
·
70
The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects
2020
·
Diede W.M. Broekaart
, Alexandra Bertran
, et al.
·
Journal of Clinical Investigation
·
63
PDF
Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics
2018
·
Salvador Guardiola
, Roger Prades
, et al.
·
Cell chemical biology
·
53
PDF
Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia
2014
·
Raquel Pinacho
, Elsa M. Valdizán
, et al.
·
Journal of Psychiatric Research
·
36
The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia
2016
·
Raquel Pinacho
, Elia Vila
, et al.
·
Schizophrenia Research
·
30
Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation
2019
·
Aleyda Benitez-Amaro
, Chiara Pallara
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
28
PDF
Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors
2019
·
Alexandra Bertran
, Danylo Khomiak
, et al.
·
Bioorganic Chemistry
·
25
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
2016
·
Roger Prades
, Eva Munarriz-Cuezva
, et al.
·
European Neuropsychopharmacology
·
25
New Trends in Brain Shuttle Peptides
2025
·
Roger Prades
, Meritxell Teixidó
, et al.
·
Molecular Pharmaceutics
·
22
HAI Peptide and Backbone Analogs—Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles
2018
·
Pol Arranz-Gibert
, Roger Prades
, et al.
·
Scientific Reports
·
18
PDF
Peptide Pop Inhibitors for the Treatment of the Cognitive Symptoms of Schizophrenia
2013
·
Abraham López
, Laura Mendieta
, et al.
·
Future Medicinal Chemistry
·
16
Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
2010
·
Axel L. Dessal
, Roger Prades
, et al.
·
Molecular Pharmacology
·
14
PDF
A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles—Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models
2019
·
Pol Arranz-Gibert
, Bernat Guixer
, et al.
·
Scientific Reports
·
13
PDF
Apolipoprotein E-enriched protein corona enhances the blood–brain barrier transport of β-sheet-breaker peptide-functionalized gold nanoparticles
2026
·
Simón Guerrero
, Natalia Hassan
, et al.
·
Colloids and Surfaces B Biointerfaces
·
12
PDF
Dual system for the central nervous system targeting and blood‐brain barrier transport of a selective prolyl oligopeptidase inhibitor
2013
·
Meritxell Teixidó
, Esther Zurita
, et al.
·
Biopolymers
·
12
Applying the Retro‐Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood–Brain Barrier
2015
·
Roger Prades
, Benjamí Oller‐Salvia
, et al.
·
Angewandte Chemie
·
10
Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization
2024
·
A. Benitez-Amaro
, E. Garcia
, et al.
·
Atherosclerosis
·
8
Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening System
2020
·
Aleyda Benitez‐Amaro
, Chiara Pallara
, et al.
·
Advanced Therapeutics
·
8
PDF
Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds
2022
·
Chiara Pallara
, Debora Cabot
, et al.
·
Scientific Reports
·
7
PDF
A novel family of diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
2009
·
Meritxell Teixidó
, Esther Zurita
, et al.
·
Advances in experimental medicine and biology
·
5
Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia
2023
·
Èlia Vila
, Raquel Pinacho
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
Does the Solid-Phase Synthesis of a Tetrapeptide Represent a Challenge at the Onset of the XXI Century? The Case of Cyclo [(3R)-3-hydroxydecanoyl-l-seryl-(3R)-3-hydroxydecanoyl-l-seryl]
2007
·
Meritxell Teixidó
, Josep Maria Caba
, et al.
·
International Journal of Peptide Research and Therapeutics
·
3
Show more works
View as search
Works count:
40
Citation count:
1,011
H-index:
14
I10-index:
19
Year
Topic
Type